23 results
8-K
EX-10.2
CRVO
CervoMed Inc
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
, software, work of authorship or other Works (as defined in Section 4.13), trade secret, innovation, trademark, data, database, or the like, whether
8-K
EX-10.3
CRVO
CervoMed Inc
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
of authorship or other Works (as defined in Section 4.13), trade secret, innovation, trademark, data, database, or the like, whether or not patentable, together
8-K
EX-10.1
x0viq7ez
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
poz8j aumd3m8vmawt
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.3
lwty nk63b
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
lmfk97
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-10.1
hr3x905k1wu75h0l
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-10.1
oost7lsm84dg6gvde
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
EX-10.1
pltss
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.2
h9c0r12izy0u 905
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am